Freakonomics, M.D. cover image

71. What Do COVID-19 and Cancer Have in Common?

Freakonomics, M.D.

00:00

T Cells and Cancer Immune Response

The number of mutations in a specific cancer is an important factor in just how effectively we can harness the immune system. Historically, highly mutated cancers have been a bad prognostic sign for patients. If you only have 10 mutations in your tumor, the likelihood of those mutations being able to stimulate T cells is low. The more mutations your body can recognize the better.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app